Publication Results (223)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »

• Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study

  Zipursky JS, Gomes T, Everett K, Calzavara A, Paterson JM, Austin PC, Mamdani MM, Ray JG, Juurlink DN. BMJ. 2023; 380:e074005. Epub 2023 Mar 15. DOI: https://doi.org/10.1136/bmj-2022-074005

• Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study

  Antoniou T, McCormack D, Kitchen S, Pajer K, Gardner W, Lunsky Y, Penner M, Tadrous M, Mamdani M, Juurlink DN, Gomes T. BMC Public Health. 2023; 23(1):85. Epub 2023 Jan 11. DOI: https://doi.org/10.1186/s12889-022-14677-6

• Changing patterns of opioid initiation for pain management in Ontario, Canada: a population-based cross-sectional study

  Gomes T, Men S, Campbell TJ, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. PLoS One. 2022; 17(12):e0278508. Epub 2022 Dec 8. DOI: https://doi.org/10.1371/journal.pone.0278508

• New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada

  Guan Q, Men S, Lunsky Y, Juurlink DN, Bronskill SE, Wunsch H, Gomes T. BJPsych Open. 2022; 8(6):e208. Epub 2022 Nov 28. DOI: https://doi.org/10.1192/bjo.2022.612

• Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: population-based cohort study

  Tadrous M, Chung H, Men S, Chu C, Campbell T, Juurlink DN, Kwong JC, Paterson JM, Gomes T. PLoS One. 2022; 17(10):e0273903. Epub 2022 Oct 20. DOI: https://doi.org/10.1371/journal.pone.0273903

• Opioid initiation and the hazard of falls or fractures among older adults with varying levels of central nervous system depressant burden

  Guan Q, Men S, Juurlink DN, Bronskill SE, Wunsch H, Gomes T. Drugs Aging. 2022; 39(9):729-38. Epub 2022 Aug 10. DOI: https://doi.org/10.1007/s40266-022-00970-x

• The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

  Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11. DOI: https://doi.org/10.3389/fphar.2022.861953

• Comparative fracture risk during osteoporosis drug holidays after long-term risedronate versus alendronate therapy: a propensity score-matched cohort study

  Hayes KN, Brown KA, Cheung AM, Kim SA, Juurlink DN, Cadarette SM. Ann Intern Med. 2022; 175(3):335-43. Epub 2022 Jan 11. DOI: https://doi.org/10.7326/M21-2512

• The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis

  Boone CG, Antoniou T, Juurlink DN, von den Baumen TR, Kitchen SA, Richards GC, Tadrous M, Gomes T. CMAJ Open. 2021; 9(4):E1181-6. Epub 2021 Dec 14. DOI: https://doi.org/10.9778/cmajo.20210173

• New opioid use and risk of emergency department visits related to motor vehicle collisions in Ontario, Canada

  Guan Q, McCormack D, Juurlink DN, Bronskill SE, Wunsch H, Gomes T. JAMA Netw Open. 2021; 4(11):e2134248. Epub 2021 Nov 11. DOI: https://doi.org/10.1001/jamanetworkopen.2021.34248

• Receipt of overactive bladder drugs and incident dementia: a population-based case-control study

  Matta R, Gomes T, Juurlink D, Jarvi K, Herschorn S, Nam, RK. Eur Urol Focus. 2021; Nov 3 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.euf.2021.10.009

• Assessment of stimulant use and cardiovascular event risks among older adults

  Tadrous M, Shakeri A, Chu C, Watt J, Mamdani MM, Juurlink DN, Gomes T. JAMA Netw Open. 2021; 4(10):e2130795. Epub 2021 Oct 25. DOI: https://doi.org/10.1001/jamanetworkopen.2021.30795

• Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada

  Martins D, Khuu W, Tadrous M, Greaves S, Sproule B, Bozinoff N, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pain. 2022; 163(1):e129-36. Epub 2021 Jul 28. DOI: https://doi.org/10.1097/j.pain.0000000000002420

• Inequities in access to primary care among opioid recipients in Ontario, Canada: a population-based cohort study

  Gomes T, Campbell TJ, Martins D, Paterson JM, Robertson L, Juurlink DN, Mamdani M, Glazier RH. PLoS Med. 2021; 8(6): e1003631. Epub 2021 Jun 1. DOI: https://doi.org/10.1371/journal.pmed.1003631

• Trends in postpartum opioid prescribing: a time series analysis

  Zipursky JS, Pang A, Paterson J, Austin PC, Mamdani M, Gomes T, Ray JG, Juurlink DN. Clin Pharmacol Ther. 2021; 110(4):1004-10. Epub 2021 May 25. DOI: https://doi.org/10.1002/cpt.2307

• Dental opioid prescription characteristics and the risk of new, persistent use

  Campbell TJ, Martins D, Tadrous M, Juurlink DN, Paterson JM, Mamdani MM, Mock D, Gomes T. Am J Prev Med. 2021; 60(6):831-9. Epub 2021 Mar 17. DOI: https://doi.org/10.1016/j.amepre.2021.01.016

• Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use

  Hayes KN, He N, Brown KA, Cheung AM, Juurlink DN, Cadarette SM. Osteoporos Int. 2021; 32(7):1413-20. Epub 2021 Jan 7. DOI: https://doi.org/10.1007/s00198-020-05794-2

• Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes

  Gomes T, Campbell T, Tadrous M, Mamdani MM, Paterson MJ, Juurlink DN. Pharmacoepidemiol Drug Saf. 2021; 30(3):379-89. Epub 2020 Dec 10. DOI: https://doi.org/10.1002/pds.5180

• Impact of policy changes on the provision of naloxone by pharmacies in Ontario Canada: a population-based time series analysis

  Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, Mamdani M, Juurlink DN, Gomes T. Addiction. 2021; 116(6):1514-20. Epub 2020 Nov 18. DOI: https://doi.org/10.1111/add.15324

• New opioid use after invasive mechanical ventilation and hospital discharge

  Wunsch H, Hill AD, Fu L, Fowler RA, Wang HT, Gomes T, Fan E, Juurlink DN, Pinto R, Wijeysundera DN, Scales DC. Am J Respir Crit Care Med. 2020; 202(4):568-75. Epub 2020 Apr 29. DOI: https://doi.org/10.1164/rccm.201912-2503OC

• Oxycodone, hydromorphone, and the risk of suicide: a retrospective population-based case-control study

  Mazereeuw G, Gomes T, Macdonald EM, Greaves S, Li P, Mamdani MM, Redelmeier DA, Juurlink DN. Drug Saf. 2020; 43(8):737-43. Epub 2020 Apr 23. DOI: https://doi.org/10.1007/s40264-020-00924-5

• Metronidazole-associated neurologic events: a nested-case control study

  Daneman N, Cheng Y, Gomes T, Guan J, Mamdani MM, Saxena FE, Juurlink DN. Clin Infect Dis. 2021; 72(12):2095-100. Epub 2020 Apr 18. DOI: https://doi.org/10.1093/cid/ciaa395

• Assessing the impact of an opioid prescribing guideline for dentists in Ontario, Canada

  Guan Q, Campbell T, Martins D, Tadrous M, Juurlink D, Paterson M, Mamadani M, Mock D, Gomes T. J Am Dent Assoc. 2020; 151(1):43-50. Epub 2019 Dec 5. DOI: https://doi.org/10.1016/j.adaj.2019.08.021

• Trends of intentional drug overdose among youth: a population-based cohort study

  Gilley M, Sivilotti MLA, Juurlink DN, Macdonald E, Yao Z, Finkelstein Y. J Clin Toxicol (Phila). 2020; 58(7):711-5. Epub 2019 Nov 24. DOI: https://doi.org/10.1080/15563650.2019.1687900

• Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide

  Mamdani M, Gomes T, Greaves S, Manji S, Juurlink DN, Tadrous M, Kennedy SH, Antoniou T. JAMA Netw Open. 2019; 2(10):e1913304. Epub 2019 Oct 16. DOI: 10.1001/jamanetworkopen.2019.13304.

• Understanding the implications of a shifting opioid landscape in Ontario

  Gomes T, Juurlink DN. Healthc Q. 2019; 22(3):6-11. Epub 2019 Oct 1. DOI: https://doi.org/10.12927/hcq.2019.26025

• One-year mortality after emergency department visit for nonfatal opioid poisoning: a population-based analysis

  Leece P, Chen C, Manson H, Orkin AM, Schwartz B, Juurlink DN, Gomes T. Ann Emerg Med. 2020; 75(1):20-8. Epub 2019 Sep 24. DOI: 10.1016/j.annemergmed.2019.07.021.

• Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older—a population-based cohort study

  Tadrous M, Matta R, Greaves S, Herschorn S, Mamdani MM, Juurlink DN, Gomes T. JAMA Intern Med. 2019; 179(10):1436-9. Epub 2019 Jul 15. DOI: https://doi.org/10.1001/jamainternmed.2019.2011

• Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada

  Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pharmacoepidemiol Drug Saf. 2019; 28(5):726-33. Epub 2019 Mar 14. DOI: 10.1002/pds.4764.

• Evaluation of the fentanyl patch-for-patch program in Ontario, Canada

  Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, Juurlink DN, Gomes T. Int J Drug Policy. 2019; 66:82-6. Epub 2019 Feb 8.

• Contributions of prescribed and non-prescribed opioids to opioid-related deaths: a population-based cohort study in Ontario, Canada

  Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. BMJ. 2018; 362:k3207. Epub 2018 Aug 29.

• Pregabalin and the risk for opioid-related death: a nested case-control study

  Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN. Ann Intern Med. 2018; 169(10):732-4. Epub 2018 Aug 21.

• Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: a multi-jurisdictional cross-sectional study

  Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Drug Alcohol Depend. 2018; 191:86-90. Epub 2018 Jul 31.

• Second-generation anti-depressants and risk of new-onset seizures in the elderly

  Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN. Clin Toxicol. 2018; 56(12):1179-84. Epub 2018 Jul 10.

• The burden of opioid-related mortality in the United States

  Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. JAMA Network Open. 2018; 1(2):e180217. Epub 2018 Jun 1.

• A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride

  Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. BMC Musculoskelet Disord. 2018; 19:160. Epub 2018 May 22.

• Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study

  Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pain. 2018; 159(8):1562-8. Epub 2018 May 16.

• Publicly funded oral chronic hepatitis B treatment patterns in Ontario over 16 years: an ecologic study

  Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T. J Manag Care Spec Pharm. 2018; 24(5):464-8. Epub 2018 Apr 26.

• Measuring the burden of opioid-related mortality in Ontario, Canada

  Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. J Addict Med. 2018; 12(5):418-9. Epub 2018 Apr 25.

• Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program

  Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T. CMAJ Open. 2018; 6(1):E132-8. Epub 2018 Mar 26.

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »